Ergebnis der Suchanfrage nach D&amp

nova-Institut GmbH

5

CO₂-based Fuels and Chemicals Conference 2026 – Call for Abstracts Now Open

UCB

UCB presents latest research and clinical advancement across leading epilepsy portfolio at International Epilepsy Congress

Brussels (ots/PRNewswire) - - 26 scientific abstracts, including two oral presentations, demonstrate UCB's ongoing commitment to advancing research for people living with epilepsies - Data include an open-label extension study describing the long-term safety of FINTEPLA®▼ (fenfluramine)[1] and global functioning ...

nova-Institut GmbH

3

Advanced Recycling Conference 2025: From Industry Crossroads to Circularity

Ottobock SE & Co. KGaA

Ottobock with strong H1 2025 results

Infineon Technologies AG

Infineon strengthens startup ecosystem in India

cooldown°earth foundation

cooldown°earth welcomes North Rhine-Westphalia (NRW) funding for matterr / – Public funds and public welfare capital accelerate circular technology -

Helmholtz Munich

2

New Endoscopy Technology Enables Early Detection of Esophageal Cancer

Drees & Sommer SE

Drees & Sommer Designs Advanced Semiconductor R&D Facility for imec in Málaga

Technische Universität München

A new biotech hub for Munich

TECHNICAL UNIVERSITY OF MUNICH NEWS RELEASE A new biotech hub for Munich Where science powers start-ups: Launching BioLabs|TUM • TUM Venture Labs cooperate with BioLabs and Lilly • 1,800 square meters of coworking lab space • Aiming at accelerating therapy development BioLabs, TUM Venture Labs, and Eli Lilly and Company (Lilly) today launched BioLabs|TUM, a new biotechnology innovation hub in central Munich. The initiative aims to empower early-stage biotech start-ups ...

Yanfeng

Yanfeng Unveils 2024 ESG Report: Driving Sustainability Forward

Helmholtz Munich

Therapeutic Vaccine for Chronic Hepatitis B Enters First Clinical Trial in Patients

PNO Innovation GmbH

TherVacB: Advance Curative Strategy for Chronic Hepatitis B

Helmholtz Munich

Cancer Cachexia: Liver Identified as Driver of Body Wasting

Many people with cancer experience dramatic loss of muscle and fat tissue. In many cases, even the heart muscle is affected, which further weakens the body. This wasting syndrome, known as cachexia, affects around half of all cancer patients. It is a major cause of therapy resistance, complications, and increased mortality. ...

Debtist GmbH

Debtist opens office in United Kingdom: Digital debt collection now also in the British market

XTEND

XTEND Secures $30M Extension to Complete $70M Series B to Scale Its Battle-Proven Autonomous AI Robots Across America

Tampa, Fla. (ots/PRNewswire) - Aliya Capital Partners and Protego Ventures Co-Lead Strategic Series B Round alongside participating investors: Len Blavatnik's Claltech, Union-Tech Ventures & Chartered Group, as XTEND's AI Robotic Technology Proves Itself in Global Conflicts and the Company Opens Its New U.S. ...

Helmholtz Munich

2

New Label-Free Imaging Tracks Cancer Treatment in Single Cells

Hellmann Worldwide Logistics

Hellmann India receives “Best Place to Work” certificate for the second year in a row

Hellmann Worldwide Logistics

2

Best practice in e-mobility: Federal and state government officials visit Hellmann in Bremen

Hellmann Worldwide Logistics

Hellmann opens state-of-the-art contract logistics center in the Melbourne metropolitan area

Hellmann Worldwide Logistics

3

Hellmann opens state-of-the-art contract logistics center in the Melbourne metropolitan area

Öko-Institut e.V.

EU climate target for 2040: Policy brief and webinar invite | Oeko-Institut | Commentary on the European Commission's draft EU Climate Law

Dear All, On 2 July 2025, the EU Commission will present a proposal for the EU climate target for 2040 and a revision of the EU Climate Law. The proposal could include a 90 per cent reduction in greenhouse gas emissions by 2040 compared to 1990 levels. Another possible component of the proposal could be the use of ...

LTS Lohmann Therapie-Systeme AG

LTS and Nualtis Announce Strategic Cooperation to Expand Global Manufacturing Capabilities, Accelerate Market Expansion, and Ensure Customer Success

Andernach / Montreal (ots) - LTS LOHMANN Therapie-Systeme AG (LTS), a leading pharmaceutical technology company, and Nualtis (formerly IntelGenx Corp.), an innovator in oral thin film (OTF) drug delivery technology, today announced a strategic collaboration to provide customers with robust, reliable, high-quality ...

Infineon Technologies AG

Tata Elxsi and Infineon Partner to Accelerate EV Innovation in India

Öko-Institut e.V.

Oxford Principles Set a New Integrity Benchmark for Using International Carbon Credits

Press release Berlin, 12 June 2025 Oxford Principles Set a New Integrity Benchmark for Using International Carbon Credits Today’s release of the Oxford Principles for Responsible Engagement with Article 6 establishes an important integrity benchmark for using international carbon credits. “The principles complement the internationally agreed rules under the Paris ...